1
Amaador, Karima, Kersten, Marie José, Visser, Otto, Brink, Mirian, Posthuma, Eduardus F.M., Minnema, Monique C., Vos, Josephine M.I., Dinmohamed, Avinash G.
Veröffentlicht in: Amaador , K , Kersten , M J , Visser , O , Brink , M , Posthuma , E F M , Minnema , M C , Vos , J M I & Dinmohamed , A G 2022 , ' Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia : a population-based study in the Netherlands, 1989–2018 ' , British Journal of Haematology , vol. 196 , no. 3 , pp. 660-669 . https://doi.org/10.1111/bjh.17856;
2022
Veröffentlicht in: Amaador , K , Kersten , M J , Visser , O , Brink , M , Posthuma , E F M , Minnema , M C , Vos , J M I & Dinmohamed , A G 2022 , ' Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia : a population-based study in the Netherlands, 1989–2018 ' , British Journal of Haematology , vol. 196 , no. 3 , pp. 660-669 . https://doi.org/10.1111/bjh.17856;
2022
2
3
4
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie José, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
5
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S.P., Zijlstra, Josée M., Chamuleau, Martine E.D., Kersten, Marie José, Plattel, Wouter J., Durmaz, Mujde, Lugtenburg, Elly, Stevens, Wendy B.C., Mous, Rogier, de Vries, Elisabeth G.E., van der Poel, Marjolein W.M., Nannan Panday, Prashant V., Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M E D , Kersten , M J , Plattel , W J , Durmaz , M , Lugtenburg , E , Stevens , W B C , Mous , R , de Vries , E G E , van der Poel , M W M , Nannan Panday , P V , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood advances , vol. 5 , no. 15 , pp. 2985-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M E D , Kersten , M J , Plattel , W J , Durmaz , M , Lugtenburg , E , Stevens , W B C , Mous , R , de Vries , E G E , van der Poel , M W M , Nannan Panday , P V , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood advances , vol. 5 , no. 15 , pp. 2985-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
6
Meeuwes, Frederik O, Brink, Mirian, Plattel, Wouter, Van der Poel, Marjolein W M, Kersten, Marie José, Wondergem, Mariëlle, Böhmer, Lara, Woei-A-Jin, F J Sherida H, Visser, Otto, Oostvogels, Rimke, Jansen, Patty M, Neelis, Karen J, Crijns, Anne P G, Daniëls, Laurien A, Snijders, Tjeerd J F, Vermaat, Joost S P, Huls, Gerwin A, Nijland, Marcel
Veröffentlicht in: Meeuwes , F O , Brink , M , Plattel , W , Van der Poel , M W M , Kersten , M J , Wondergem , M , Böhmer , L , Woei-A-Jin , F J S H , Visser , O , Oostvogels , R , Jansen , P M , Neelis , K J , Crijns , A P G , Daniëls , L A , Snijders , T J F , Vermaat , J S P , Huls , G A & Nijland , M 2024 , ' Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands ' , Haematologica , vol. 109 , no. 4 , pp. 1163-1170 . https://doi.org/10.3324/haematol.2023.283174;
2024
Veröffentlicht in: Meeuwes , F O , Brink , M , Plattel , W , Van der Poel , M W M , Kersten , M J , Wondergem , M , Böhmer , L , Woei-A-Jin , F J S H , Visser , O , Oostvogels , R , Jansen , P M , Neelis , K J , Crijns , A P G , Daniëls , L A , Snijders , T J F , Vermaat , J S P , Huls , G A & Nijland , M 2024 , ' Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands ' , Haematologica , vol. 109 , no. 4 , pp. 1163-1170 . https://doi.org/10.3324/haematol.2023.283174;
2024